本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Redhill Biopharma Ltd

2.26
+0.19009.18%
盘后2.25-0.0100-0.44%19:57 EDT
成交量:132.19万
成交额:304.84万
市值:395.95万
市盈率:-0.34
高:2.49
开:1.93
低:1.90
收:2.07
数据加载中...
2025/04/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC问询函

Form CORRESP - Correspondence
2024/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/08

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/09

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/26

SEC问询函

Form CORRESP - Correspondence
2023/08/10

SEC问询函

Form CORRESP - Correspondence
2023/06/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals